TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis
Author(s) -
Jin Wang,
Xuejiao Wang,
Yan Zhang,
Wenjuan Shi,
Zhandong Lei,
Xiangying Jiao
Publication year - 2022
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt-21-732
Subject(s) - txnip , medicine , angiogenesis , vascular endothelial growth factor , thioredoxin interacting protein , protein kinase b , cardiac function curve , tunel assay , apoptosis , endocrinology , cancer research , biology , immunohistochemistry , heart failure , oxidative stress , thioredoxin , biochemistry , vegf receptors
Myocardial infarction (MI) is a common cause of death. Thioredoxin-interacting protein (TXNIP) expression increases after MI, and it exerts a negative regulatory effect on cardiac function after MI. Our study aimed to investigate the specific regulatory mechanism of TXNIP on angiogenesis and cardiomyocyte apoptosis after MI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom